key: cord-262180-t4akem15
authors: Cheruiyot, Isaac
title: Comment on “Encephalopathy in patients with COVID‐19: A review”
date: 2020-07-11
journal: J Med Virol
DOI: 10.1002/jmv.26238
sha: 
doc_id: 262180
cord_uid: t4akem15

I read with great interest the article by Garg and colleagues on "Encephalopathy in patients with COVID-19: A review". The authors performed a review of published reports on COVID-19-associated encephalitis and encephalopathy. This article is protected by copyright. All rights reserved.

The author received no financial support for the research, authorship, and/or publication of this article.

The author does not have any conflicts of interest with regard to this publication.

School of Medicine, University of Nairobi, Nairobi, Kenya 

Encephalopathy in patients with COVID-19: a review

Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke

Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2

Guillain-Barré syndrome after SARS-CoV-2 infection

Validation of SARS-CoV-2 detection across multiple specimen types

Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

Sars-Cov-2: underestimated damage to nervous system

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF

Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease

Lamballerie de X. How many patients with anti-JEV IgM in cerebrospinal fluid really have Japanese encephalitis?

Dengue in patients with central nervous system manifestations

Importance of cerebrospinal fluid investigation during dengue infection in Brazilian Amazonia Region